<DOC>
	<DOCNO>NCT01693393</DOCNO>
	<brief_summary>Sandimmun optoral ( Cyclosporin A ) use musculoskeletal manifestation Primary Sjögren Syndrome</brief_summary>
	<brief_title>Low Dose Cyclosporin A Primary Sjögren Syndrome</brief_title>
	<detailed_description>NSAR use currently treatment musculoskeletal manifestation Sjögren Syndrome symptomatic release pain . For therapy-resistant case drug also use Rheumatoid Arthritis use . For drug registration treatment Sjögren Syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Diagnosis primary Sjögren´s Syndrome Liver value 1,5 ULN uncontrolled arterial hypertension intraarticular systemic use Glucocorticoids last 4 week begin Study medication pretreatment Cyclosporine A Infection Neoplasia relevant cardiac , pulmonary , neurologic psychiatric disease lifeVaccination within 4 week begin study medication pregnant breastfeeding weight 45kg 110kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>primary Sjogren´s Syndrome</keyword>
	<keyword>Cyclosporine</keyword>
</DOC>